Group 1 - The core point of the announcement is that the shareholder Beijing Quantum Leap Technology Co., Ltd. plans to reduce its stake in Zhangyue Technology by selling up to 4,388,968 shares, which represents 1% of the company's total share capital, within three months starting from 15 trading days after the announcement date [2][3][8] - As of the announcement date, Quantum Leap holds 26,257,246 shares, accounting for 5.98% of the total share capital, all acquired through a private transfer [2][3] - The reduction plan is in line with previous commitments made by the major shareholders regarding shareholding and transfer restrictions, ensuring compliance with relevant regulations [6][7] Group 2 - The reduction plan will be subject to market conditions and the company's stock price trends, introducing uncertainty regarding the timing, quantity, and price of the share sales [8] - The announcement confirms that the reduction will not lead to a change in the control of the listed company [8] - The company will adhere to legal requirements and timely disclose any updates regarding the implementation of the reduction plan [8]

Mergers and Acquisitions - Lianjian Technology plans to acquire 55% equity of Zhongding Testing for 101 million yuan, making it a subsidiary included in the consolidated financial statements after the transaction [1] Termination of Asset Purchase - Yaxing Chemical announced the termination of its plan to issue shares and pay cash for the acquisition of 100% equity of Shandong Tianyi Chemical, which was expected to constitute a major asset restructuring [2] Earnings Disclosure - Kanglong Chemical expects a net profit of 1.614 billion to 1.686 billion yuan for 2025, a year-on-year decrease of 6% to 10%, while revenue is projected to grow by 13% to 16% [3] - Yongyou Network anticipates a net loss of 1.3 billion to 1.39 billion yuan for 2025, reducing losses by 671 million to 761 million yuan year-on-year [4] - Dongpeng Beverage expects a net profit of 4.34 billion to 4.59 billion yuan for 2025, an increase of 1.013 billion to 1.263 billion yuan, representing a growth of 30.46% to 37.97% [5] - Pudong Development Bank forecasts a net profit of 50.017 billion yuan for 2025, a year-on-year increase of 10.52%, with revenue expected to be 173.964 billion yuan, up 1.88% [6] Shareholding Changes - Zhang Yijie, a shareholder of Jixin Technology, plans to reduce holdings by up to 969,030 shares, not exceeding 1% of the total share capital, for personal financial needs [8] - Quantum Leap, a shareholder of Zhangyue Technology, intends to reduce its stake by up to 438,900 shares, not exceeding 1% of the total share capital, due to personal needs [7] - Alibaba Health, a major shareholder of Shuyupingmin, plans to reduce its holdings by up to 810,720 shares, accounting for 2% of the total share capital, for personal financial needs [9] - Anyang Qixu, a shareholder of Xiangyu Medical, intends to reduce its stake by up to 480,000 shares, not exceeding 3% of the total share capital, due to personal financial needs [10] Risk Matters - *ST Lifang announced that its stock price has fallen below 1 yuan, which may lead to delisting due to the stock price being below par value, and it has received a notice of administrative penalty for false records in annual reports from 2021 to 2023 [11]

Core Viewpoint - The announcement from Zhangyue Technology indicates that its shareholder, Quantum Leap Technology, plans to reduce its stake in the company through a share reduction plan, which may impact the stock performance and investor sentiment [2] Group 1: Shareholder Information - Quantum Leap Technology holds 26,257,246 shares of Zhangyue Technology, representing 5.98% of the total share capital [2] - The planned reduction involves a maximum of 4,388,968 shares, which is approximately 1% of the total share capital [2] Group 2: Reduction Plan Details - The reduction period is set to begin 15 trading days after the announcement date and will last for three months [2] - During any consecutive 90-day period, the total number of shares reduced cannot exceed 1% of the company's total share capital [2]

Group 1: Share Buybacks and Increases - Prolo Pharmaceutical's controlling shareholder plans to increase its stake by 60 million to 120 million yuan [3] - BAIC Blue Valley and some directors and executives plan to increase their holdings by 14.5 million to 16.4 million yuan [3] - Zhongju High-tech has obtained a commitment letter for a stock repurchase loan of 540 million yuan from a financial institution [3] - Haojiang Intelligent plans to use its own funds to repurchase shares for equity incentives or employee stock ownership plans [3] - Huazhi Jie intends to repurchase shares worth 30 million to 50 million yuan [3] - Nanshan Aluminum plans to repurchase shares worth 300 million to 600 million yuan for cancellation [3] Group 2: Share Reductions - New Work Group, a shareholder of Zhongxin Group, plans to reduce its stake by no more than 3% [3] - Hongqi Technology's shareholders plan to reduce their holdings by no more than 4.68% [3] - Zhejiang Yongqiang's shareholder, Xie Jianqiang, plans to reduce his stake by no more than 1.13% [3] - Xiangyu Medical's shareholder, Anyang Qixu, plans to reduce his stake by no more than 3% [3] - Shuyuan Pingmin's shareholder, Ali Health, plans to reduce his stake by no more than 2% [3] - Hongqiang Co., Ltd.'s actual controller plans to reduce no more than 2.1161 million shares, not exceeding 1% of the total share capital [3] - China Merchants Shipping's directors and executives plan to collectively reduce their holdings by no more than 648,600 shares [3] - Zhang Yijie, a shareholder of Jixin Technology, plans to reduce his stake by no more than 1% [3] - Dingjie Smart's major shareholder, Industrial Fulian, reduced its stake by 1.14% from January 9 to January 12 [3] - Zhongli Co., Ltd.'s shareholders plan to reduce their holdings by no more than 0.75% [3]

Shareholder Reduction - New China Group's shareholder, New Work Group, plans to reduce its stake by no more than 3% [1] - Shuyuan Pingmin's shareholder, Alibaba Health, intends to reduce its stake by no more than 2% [1] - Zhejiang Yongqiang's shareholder, Xie Jianqiang, plans to reduce his stake by no more than 1.13% [1] - Xiangyu Medical's shareholder, Anyang Qixu, intends to reduce his stake by no more than 3% [1] - Zhangyue Technology's shareholder, Quantum Leap, plans to reduce its stake by no more than 1% [1] - Fudan Zhangjiang's shareholder, Yang Zongmeng, has reduced 10.3657 million shares [1] - Saiwei Times' shareholder, Zhongteng Investment, has reduced 12.1037 million shares [1] - Aokang International's shareholder, Xiang Jinyu, has cumulatively reduced 1.21% of the company's shares [1] - Fute Technology's shareholder, Changjiang Weilai Industrial Fund, has cumulatively reduced 1.6492% of the shares [1] - New Giant's shareholder, Suzhou Houqi, has cumulatively reduced 1.4997% of the shares [1] - Baolingbao's shareholder, De Pufutong, has cumulatively reduced 1.10689% of the shares [1] - Hongqiang's actual controller, Liu Lianjun, plans to reduce his stake by no more than 1% [1] - Yashiguangdian's shareholder, Bian Ruiqun, has cumulatively reduced 1.0695% of the shares [1] Other Financial Issues - Ruimao Tong has reported overdue debts amounting to approximately 856 million yuan [1] - *ST Dongjing is under investigation by the Securities Regulatory Commission due to independent director Fu Baoshan's suspected insider trading [1]

格隆汇1月13日丨掌阅科技(603533.SH)公布，2026年1月13日，公司收到股东量子跃动发来的《关于股 份减持计划的告知函》，量子跃动因自身需要，拟通过集中竞价减持公司股份，合计不超过438.90万 股，减持期间为本公告披露之日起15个交易日后的3个月内，且在任意连续90个自然日内减持股份总数 不超过公司股本总数的1%。若减持计划实施期间公司发生送股、资本公积金转增股本等股份变动事 项，减持股份数量将进行相应调整。 ...

Core Viewpoint - The announcement reveals that a major shareholder, Beijing Quantum Leap Technology Co., Ltd., plans to reduce its stake in Zhangyue Technology Co., Ltd. through a share reduction plan [1] Group 1: Shareholder Information - Beijing Quantum Leap Technology Co., Ltd. holds 26,257,246 shares in Zhangyue Technology, representing 5.98% of the total share capital [1] - The shares were acquired through a private transfer [1] Group 2: Share Reduction Plan - The shareholder intends to reduce its holdings by up to 4,388,968 shares [1] - The reduction period is set to begin 15 trading days after the announcement and will last for three months [1] - During any consecutive 90-day period, the total number of shares reduced will not exceed 1% of the company's total share capital [1]

证券代码：603533 证券简称：掌阅科技 公告编号：2026-003 减持计划的主要内容 2026 年 1 月 13 日，公司收到上述股东发来的《关于股份减持计划的告知函》， 量子跃动因自身需要，拟通过集中竞价减持公司股份，合计不超过 4,388,968 股， 减持期间为本公告披露之日起 15 个交易日后的 3 个月内，且在任意连续 90 个自 然日内减持股份总数不超过公司股本总数的 1%。若减持计划实施期间公司发生 送股、资本公积金转增股本等股份变动事项，减持股份数量将进行相应调整。 一、减持主体的基本情况 掌阅科技股份有限公司 股东集中竞价减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东持股的基本情况 截至本公告披露日，公司股东北京量子跃动科技有限公司（以下简称"量子 跃动"）持有掌阅科技股份有限公司（以下简称"公司"）26,257,246 股，占公司 股本总数的 5.98%，上述股份均为协议转让取得。 预披露期间，若公司股票发生停牌情形的，实际开始减持的时间根据停牌时间相 ...

21智讯1月13日电，掌阅科技公告，截至公告披露日，公司股东北京量子跃动科技有限公司（简称"量子 跃动"）持有公司26,257,246股，占公司总股本的5.98%。因自身需要，量子跃动拟通过集中竞价交易方 式减持公司股份不超过438.9万股，即不超过公司总股本的1.00%，减持期间为2026年2月5日至2026年5 月6日。在任意连续90个自然日内，减持股份总数不超过公司股本总数的1%。若减持期间公司发生送 股、资本公积金转增股本等事项，减持股份数量将相应调整。本次减持计划符合相关法律法规规定，减 持实施存在不确定性，公司将根据进展情况及时履行信息披露义务。 ...

Core Viewpoint - The short drama sector is thriving, but rising promotional costs are leading to a situation where top companies are experiencing "increased revenue without increased profit" [1] Group 1: Company Performance - Zhangyue Technology reported its first annual loss since its IPO in 2017, with an expected net profit attributable to shareholders being negative for 2025 [1] - The company has incurred a cumulative loss of 217 million yuan in the first three quarters of 2025, a year-on-year increase of 488.26% [1] - Despite a positive trend of "revenue growth and narrowing losses" in the third quarter, the overall profitability remains under pressure due to high short drama investment [1][6] Group 2: Business Transformation - Established in 2008, Zhangyue Technology initially focused on digital reading services and later shifted its focus to short dramas as a new growth avenue [2] - The company has transitioned from hardware sales, which were sold off in 2019 due to losses, to a focus on short dramas and derivative businesses [2] - In 2023, derivative businesses began to replace copyright products as the new growth driver, indicating a significant shift in revenue sources [6] Group 3: Revenue and Cost Structure - In 2024, digital reading revenue decreased by 25.91%, while short drama and derivative businesses surged by 189.99% to 776 million yuan, contributing to 30% of total revenue [7] - For the first half of 2025, Zhangyue Technology achieved a revenue of 1.526 billion yuan, a year-on-year increase of 14.58%, with short drama revenue reaching 838 million yuan, up 149.09% [7] - Sales expenses for the first three quarters of 2025 totaled 1.676 billion yuan, accounting for 68.1% of revenue, a 10 percentage point increase from 2024 [8] Group 4: Future Outlook - The company plans to optimize domestic short drama operations while focusing on overseas expansion and enhancing the quality and profitability of projects [8] - Zhangyue Technology is also exploring AI-related hardware, indicating a potential diversification of its business model [9] - The stock price has seen a significant increase of over 40% in the past week, reflecting market interest despite a 60% decline from its IPO peak [9]